Central nervous system toxicity of high‐dose systemic cytosine arabinoside

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Cancer

• Publication date

  1981-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19811215)48:12<2577::AID-CNCR2820481207>3.0.CO;2-ZPMID 7306918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Central nervous system involvement at presentation in acute granulocytic leukemia. A prospective cytocentrifuge study.

  1980cited by this paper
• Cytarabine-induced anaphylaxis. Demonstration of antibody and successful desensitization.

  1980cited by this paper
• Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy.

  1979cited by this paper
• Cytarabine-induced inflammation in the seborrheic keratoses of Leser-Trélat.

  1979cited by this paper
• Paraplegia following intrathecal cytosine arabinoside

  1979cited by this paper
• High dose cytosine arabinoside (HDARAC) in refractory acute leukemia

  1979cited by this paper
• Mucocutaneous side effects of cancer chemotherapy.

  1978cited by this paper
• Abnormal CT Scans of the Brain in Asymptomatic Children with Acute Lymphocytic Leukemia after Prophylactic Treatment of the Central Nervous System with Radiation and Intrathecal Chemotherapy

  1978cited by this paper
• Central nervous system involvement in patients with histiocytic lymphoma, diffuse type.

  1978cited by this paper
• Central nervous system involvement in patients with histiocytic lymphoma, diffuse type [letter]

  1978cited by this paper
• Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols. A clinical‐pathologic study of 33 patients

  1978cited by this paper
• Seizures following intrathecal cytosine arabinoside in young children with acute lymphoblastic leukemia

  1978cited by this paper
• Hepatotoxicity of combination chemotherapy for acute myelocytic leukemia.

  1977cited by this paper
• High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvement.

  1977cited by this paper
• Physiologic disposition of cytosine arabinoside and its derivatives in man.

  1977cited by this paper
• Potential advances in the clinical use of arabinosyl cytosine.

  1977cited by this paper
• Paraparesis following intrathecal cytosine arabinoside. A case report with neuropathologic findings

  1977cited by this paper
• Clinical pharmacology of anticancer drugs.

  1977cited by this paper
• Hepatitis antigen in pleural fluid.

  1977cited by this paper
• Progress in the treatment of adults with acute leukemia: review of regimens containing cytarabine studied by the Southwest Oncology Group.

  1976cited by this paper
• Disseminated necrotizing leukoencephalopathy: A complication of treated central nervous system leukemia and lymphoma

  1975cited by this paper
• Experimental necrosis and arrest of proliferation of Schwann cells by cytosine arabinoside

  1975cited by this paper
• Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia

  1975cited by this paper
• Letter: Early breast cancer and postoperative irradiation.

  1975cited by this paper
• Cytarabine and its effect on cerebellum of suckling mouse.

  1975cited by this paper
• A COMPARISON OF THE EFFECTS OF CYTOSINE ARABINOSIDE AND ADENINE ARABINOSIDE ON SOME ASPECTS OF BRAIN GROWTH AND DEVELOPMENT IN THE RAT

  1975cited by this paper
• Letter: neuropathy due to cytosine arabinoside.

  1974cited by this paper
• Neurotoxicity of commonly used antineoplastic agents (second of two parts).

  1974cited by this paper
• The incidence of central nervous system leukemia in adults with acute leukemia

  1974cited by this paper
• Letter: Febrile response to cytarabine.

  1974cited by this paper
• Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic response.

  1974cited by this paper
• Neurotoxicity of commonly used antineoplastic agents (first of two parts).

  1974cited by this paper
• Effect of the Antiviral Drug, Cytosine Arabinoside, on the Developing Nervous System

  1974cited by this paper
• Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.

  1974cited by this paper
• Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide.

  1974cited by this paper
• Neurological complications of acute leukemia in adults: changing rate.

  1973cited by this paper
• Treatment of central nervous system leukemia with intrathecal cytosine arabinoside

  1973cited by this paper
• Pharmacologic and cytokinetic studies of arabinosyl cytosine.

  1973cited by this paper
• Paraplegia following intrathecal chemotherapy

  1972cited by this paper
• Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosine

  1971cited by this paper
• Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.

  1971cited by this paper
• Intrathecal arabinosyl cytosine in meningeal leukemia

  1970cited by this paper
• 5-Fluorouracil in Cancer: An Improved Regimen

  1970cited by this paper
• Prolonged infusion of arabinosyl cytosine in childhood leukemia

  1970cited by this paper
• The acute cerebellar syndrome in 5-fluorouracil chemotherapy: a manifestation of fluoroacetate intoxication.

  1970cited by this paper
• Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults.

  1969cited by this paper
• Biochemical basis of the acute cerebellar syndrome in 5-fluorouracil chemotherapy.

  1969cited by this paper
• Intrathecal methotrexate.

  1969cited by this paper
• Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878).

  1969cited by this paper
• Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults.

  1968cited by this paper
• Clinical pharmacology and human antitumor activity of cytosine arabinoside

  1967cited by this paper
• Chemotherapy of leukemia L1210 in mice with 1-beta-D-arabinofuranosylcytosine hydrochloride. II. Effectiveness against intracerebrally and subcutaneously inoculated leukemic cells.

  1966cited by this paper

• Neuro-toxicities of chemo- and immune-therapies in haematologic malignancies: from mechanism to management.

  2024cites this paper
• Neurodevelopmental Process Monitoring of Cytosine Arabinoside-Exposed Neurons Using Raman Spectroscopy

  2024influential citation
• AraC interacts with p75NTR transmembrane domain to induce cell death of mature neurons

  2023cites this paper
• Third cranial nerve palsy: An unusual presentation of cytarabine toxicity

  2023cites this paper
• Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience

  2021cites this paper
• Consolidation in AML: Abundant opinion and much unknown.

  2021cites this paper
• AraC binds the p75NTR transmembrane domain to induce neurodegeneration in mature neurons

  2021cites this paper
• Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action

  2020cites this paper
• ACUTE CENTRAL NERVOUS SYSTEM COMPLICATIONS AND SECONDARY MENINGIOMAS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA

  2020cites this paper
• Successful treatment of cytarabine-related neurotoxicity with corticosteroids, a case series

  2018cites this paper
• COVER 4_07

  2018cites this paper
• Pediatric Iatrogenic Movement Disorders.

  2018cites this paper
• The Effect of Special Diets on Weight and Nutritional Intake in Hematological Cancer Patients: A Randomized Study

  2018cites this paper
• The Complex Diagnostic Challenge in Children With Non–Central Nervous System Cancer and Cerebellar Mutism

  2017cites this paper
• The Prevalance of Sensori-Neural Hearing Loss and Ototoxicity in AcuteMyeloid Leukemia Patients

  2017cites this paper
• The usefulness of sLORETA in evaluating the effect of high-dose ARA-C on brain connectivity in patients with acute myeloid leukemia: an exploratory study.

  2017cites this paper
• Induction of Synthetic Lethality by Natural Compounds Targeting Cancer Signaling.

  2017cites this paper
• Effect of high dose cytosine arabinoside on quantitative EEG in patients with acute myeloid leukemia

  2016cites this paper
• Separating chemotherapy-related developmental neurotoxicity from cytotoxicity in monolayer and neurosphere cultures of human fetal brain cells.

  2016cites this paper
• Electrical stimulation inhibits cytosine arabinoside-induced neuronal death by preventing apoptosis in dorsal root ganglion neurons

  2016cites this paper
• The double-edged sword: Neurotoxicity of chemotherapy.

  2015cites this paper
• Female Gender and Hispanic Ethnicity are Associated with Increased Risk of Subacute Methotrexate Encephalopathy

  2015cites this paper
• Potential Clinical Uses of CDK Inhibitors: Lessons from Synthetic Lethality Screens

  2015cites this paper
• An update on the cerebellar subtype of multiple system atrophy

  2014cites this paper
• Drug-Induced Cerebellar Ataxia: A Systematic Review

  2014cites this paper
• Uptake Carriers and Oncology Drug Safety

  2014cites this paper
• Microsoft Word-32560990-file00

  2013cites this paper
• Rehabilitation for Ataxia Following Chemotherapy for Burkitt Lymphoma Involving the Rectum

  2012cites this paper
• Psychopharmacology in Pediatric Oncology

  2012cites this paper
• patients receiving marrow transplants for acute leukemia The risks of central nervous system relapse and leukoencephalopathy in

  2011cites this paper
• Sporadic ataxia with adult onset: classification and diagnostic criteria.

  2010cites this paper
• Acute meningitis and cerebellar dysfunction complicating high-dose cytosine arabinoside therapy.

  2009cites this paper
• Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma.

  2009cites this paper
• Dose-related pharmacologic effects of high dose ara-C and its use in combination with asparaginase for the treatment of patients with acute non-lymphocytic leukemia.

  2009cites this paper
• Severe persistent cerebellar dysfunction complicating cytosine arabinoside therapy.

  2009cites this paper
• Cerebellar dysfunction during high dose cytosine arabinoside therapy in a case of acute myelogenous leukaemia.

  2009cites this paper
• AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity

  2008cites this paper
• Neurologic Complications of Chemotherapy

  2008cites this paper
• [Ultrahigh-dosage cytostatics--their possible use in acute leukemias?].

  2008cites this paper
• Managing Patients With Acute Myeloid Leukemia—Importance of Supportive Care Measures

  2008cites this paper
• Studies of cerebral blood flow and cerebrospinal fluid in childhood acute lymphoblastic leukemia

  2008cites this paper
• Neuroimaging of Toxic and Metabolic Disorders

  2008cites this paper
• Chapter 2 Acquired Cerebellar Ataxias and Differential Diagnosis

  2007cites this paper
• Reversible posterior leukoencephalopathy syndrome after repeat intermediate‐dose cytarabine chemotherapy in a patient with acute myeloid leukemia

  2007cites this paper
• Essential postmitochondrial function of p53 uncovered in DNA damage-induced apoptosis in neurons

  2007cites this paper
• Postmitochondrial regulation of apoptosis in neurons and cancer cells

  2007cites this paper
• Chromatin modification of Apaf-1 restricts the apoptotic pathway in mature neurons

  2007influential citation
• An Inhibitor of DNA Recombination Blocks Memory Consolidation, But Not Reconsolidation, in Context Fear Conditioning

  2006influential citation
• Evaluation of cognition in cancer patients: special focus on the elderly.

  2006cites this paper
• Plasma and Cerebrospinal Fluid Pharmacokinetics of 1-ß-D-Arabino-furanosy Icytosine and 1-ß-D-Arabinofuranosyluracil following the Repeated Intravenous Administration of High- and Intermediate-Dose l -ß-D-Arabinofuranosylcytosine1

  2006cites this paper
• Neuronal apoptosis and gray matter heterotopia in microcephaly produced by cytosine arabinoside in mice.

  2006cites this paper
• The activation loop phosphorylation of protein kinase D is an early marker of neuronal DNA damage

  2006cites this paper
• Central nervous system pharmacokinetics of high-dose cytosine arabinoside

  2005cites this paper
• Drug-induced aseptic meningitis

  2005cites this paper
• High-dose cytosine arabinoside: pharmacological and clinical aspects

  2004cites this paper
• Severe neurotoxicity caused by gemcitabine treatment

  2004cites this paper
• A phase II study of high-dose cytosine arabinoside in the treatment of acute leukaemia in adults

  2004cites this paper
• Cerebellar sclerosis in pediatric cancer patients

  2004cites this paper
• Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin

  2004cites this paper
• Cerebellar toxicity during cytarabine therapy associated with renal insufficiency

  2004influential citation
• Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide

  2004cites this paper
• Cytosine arabinoside rapidly activates Bax-dependent apoptosis and a delayed Bax-independent death pathway in sympathetic neurons

  2003cites this paper
• Patterned Purkinje cell death in the cerebellum.

  2003cites this paper
• adults chemotherapy for the treatment of acute myelogenous leukemia in High-dose cytarabine and daunorubicin induction and postremission

  2003cites this paper
• JNK-independent Activation of c-Jun during Neuronal Apoptosis Induced by Multiple DNA-damaging Agents*

  2003cites this paper
• Neurotoxicity in children after treatment for acute lymphoblastic leukaemia and methotrexate neurotoxicity in a controlled animal model

  2003cites this paper
• Neurologic complications of hematologic neoplasms.

  2003cites this paper
• Brain injury: current management and investigations.

  2003cites this paper
• Purkinje cells: a significant target for neurotoxicity

  2002cites this paper
• Pharmacokinetics of 2-chlorodeoxyadenosine in a child undergoing hemofiltration and hemodialysis for acute renal failure.

  2002cites this paper
• Penicillamine‐induced lethal status dystonicus in a patient with Wilson's disease

  2001cites this paper
• Permanent cerebellar toxicity of cytosine arabinoside (Ara C) in a young woman

  2001cites this paper
• Toxicological testing of cytotoxic drugs (review).

  2001cites this paper
• Restless legs syndrome in an Asian population: A study in Singapore

  2001cites this paper
• Hemichorea, moya‐moya, and ulcerative colitis

  2001cites this paper
• Deep brain stimulation of the internal pallidum did not improve chorea in a patient with neuro‐acanthocytosis

  2001cites this paper
• Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013.

  2000cites this paper
• Drug-Induced Aseptic Meningitis

  2000cites this paper
• Short-term Changes in Lower Leg Length in Children Treated for Acute Lymphoblastic Leukaemia

  1999cites this paper
• CEREBELLAR TOXICITY FOLLOWING HYPERCVAD REGIMEN FOR ACUTE LYMPHOBLASTIC LEUKAEMIA

  1999cites this paper
• CD34+CD38−HLA‐DR− CORRELATE MORE CLOSELY THAN CD34+CD38− WITH ENGRAFTMENT POST‐PBSC TRANSPLANTATION

  1999cites this paper
• Contribution of single-photon emission computed tomography in the diagnosis and follow-up of CNS toxicity of a cytarabine-containing regimen in pediatric leukemia.

  1999cites this paper
• Acute basal ganglia necrosis associated with cytarabine therapy.

  1998cites this paper
• Reversible parkinsonism in a child after bone marrow transplantation and lipid-based amphotericin B therapy.

  1998cites this paper
• An anthropometric study of children during intensive chemotherapy for acute lymphoblastic leukaemia.

  1997cites this paper
• High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.

  1997cites this paper
• Use of two‐dimensional gel electrophoresis to characterize protein synthesis during neuronal death in cerebellar culture

  1996cites this paper
• NONMEM population pharmacokinetic studies of cytosine arabinoside after high-dose and after loading bolus followed by continuous infusion of the drug in pediatric patients with leukemias

  1996cites this paper
• High-dose ara-C in older adults with acute leukemia.

  1996cites this paper
• Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patients

  1996cites this paper
• High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma.

  1996cites this paper
• Acute pancreatitis associated with continuous infusion cytarabine therapy: A case report

  1996cites this paper
• Acute Pancreatitis Associated with Continuous Infusion Cytarabine Therapy

  1996cites this paper
• Transient Ara-C leukoencephalopathy: MR findings.

  1996cites this paper
• Cytostatic-Induced Central Nervous System Abnormalities

  1995cites this paper
• Clinical Neurotoxic Concerns on Antineoplastic Agents

  1995cites this paper
• Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function.

  1995cites this paper
• Cytosine Arabinoside Induces Apoptosis in Cerebellar Neurons in Culture

  1995cites this paper
• Symptom management: loss of concentration.

  1995cites this paper
• Neurotoxicity secondary to antineoplastic drugs.

  1994cites this paper